CD34 and acute myeloid leukemia: When comparing the overall results, the authors observed that there was no statistically significant difference between the leukemic and normal cells, but the AML cells showed a wider variation with 21% of the patients showing higher and 12% showing lower levels than the normal CD34+ bone marrow cells.